Recovery of Platelet Function After a Loading Dose of Prasugrel or Clopidogrel in Aspirin-Treated Subjects Presenting With Symptoms of Acute Coronary Syndromes.

Trial Profile

Recovery of Platelet Function After a Loading Dose of Prasugrel or Clopidogrel in Aspirin-Treated Subjects Presenting With Symptoms of Acute Coronary Syndromes.

Discontinued
Phase of Trial: Phase I

Latest Information Update: 01 Jan 2013

At a glance

  • Drugs Prasugrel (Primary) ; Clopidogrel
  • Indications Coronary artery disease; Embolism and thrombosis
  • Focus Pharmacodynamics
  • Sponsors Eli Lilly
  • Most Recent Events

    • 08 Feb 2011 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 01 Nov 2010 Planned End Date changed from 1 Feb 2011 to 1 Oct 2011 as reported by ClinicalTrials.gov.
    • 24 Apr 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top